MSC-DC

MSC-DC is a cell therapy product based on mesenchymal stem cells (MSCs). These are multipotent stromal cells capable of differentiating into various cell types, including osteoblasts, chondrocytes, and adipocytes. The "DC" in the name may refer to dendritic cell modification or co-culture, but specific details for this formulation are not provided in the available sources. Generally, MSC-based therapies are developed for their immunomodulatory and regenerative properties. They have been investigated for a range of indications such as graft-versus-host disease (GvHD), Crohn's disease-related fistulas, myocardial infarction, osteoarthritis, and other inflammatory or degenerative conditions[1]. The mechanism of action typically involves modulation of immune responses (e.g., regulation of T-cell activity) and promotion of tissue repair through paracrine signaling[2]. Manufacturing requires compliance with Good Manufacturing Practices (GMP), including donor tissue acquisition, cell isolation/expansion/culturing/freeze-storage steps[1].

Other names

MSC-DC制剂